BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3748800)

  • 1. [Importance of standardization in the biological monitoring of anti-vitamin K therapy].
    Forestier F; Boneu B; Potron G; Boisseau M; Coqueret B; Saffar S; Chambrette B
    Nouv Rev Fr Hematol (1978); 1986; 28(3):157-62. PubMed ID: 3748800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation.
    Thorp JA; Caspers DR; Cohen GR; Zucker ML; Strope BD; McKenzie DR
    Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison between the dilution curves of prothrombin time and activated partial thromboplastin time for the control of the effect of anti-vitamin K].
    Langer B; Fuess VL; Kauffman P; Bechara MJ; dos Reis JM; Kwang WT
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):18-22. PubMed ID: 6385200
    [No Abstract]   [Full Text] [Related]  

  • 5. [Suggestions and propositions to resolve some issues for standardization of prothrombin time and activated partial thromboplastin time].
    Kagawa K; Fukutake K
    Rinsho Byori; 1999 May; 47(5):431-7. PubMed ID: 10375964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laboratory control of the effect of anti-vitamins K on blood coagulation].
    Langer B; Muraco B; Manasterski J; Bechara MJ; Sitrângulo Júnior C; Puech-Leão LE
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):12-7. PubMed ID: 6484435
    [No Abstract]   [Full Text] [Related]  

  • 7. [Monitoring of coagulation status in the physician's laboratory].
    Marbet GA
    Ther Umsch; 1995 May; 52(5):343-9. PubMed ID: 7770821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of reagent and instrument on prothrombin times, activated partial thromboplastin times and patient/control ratios.
    Naghibi F; Han Y; Dodds WJ; Lawrence CE
    Thromb Haemost; 1988 Jun; 59(3):455-63. PubMed ID: 3187932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulant therapy and international normalized ratios in swine.
    McGlasson DL; Brickey DA; Doe RH
    Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action and monitoring of anticoagulants.
    Hirsh J
    Semin Thromb Hemost; 1986 Jan; 12(1):1-11. PubMed ID: 3961504
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term French experience in INR standardization by a procedure using plasma calibrants.
    Houbouyan LL; Goguel AF
    Am J Clin Pathol; 1997 Jul; 108(1):83-9. PubMed ID: 9208983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is duplicate testing for prothrombin time and activated partial thromboplastin time necessary?
    Keshgegian AA; Mann JM; Cooper JH
    Arch Pathol Lab Med; 1986 Jun; 110(6):520-2. PubMed ID: 3754725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of drawing a discard tube on PT and APTT results in healthy adults.
    Bamberg R; Cottle JN; Williams JC
    Clin Lab Sci; 2003; 16(1):16-9. PubMed ID: 12587654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laboratory control of anticoagulant treatments (author's transl)].
    Samama M; Conard J; Horellou MH
    J Mal Vasc; 1981; 6(4):257-61. PubMed ID: 7320641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How can we improve long-term anticoagulation?].
    Beck EA
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1495-500. PubMed ID: 4081678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems with assays based on fibrin clot formation principle: analysis of multilaboratory data.
    Hirai N; Tatsumi N; Hino M; Yamane T; Ohta K
    Osaka City Med J; 1998 Jun; 44(1):55-71. PubMed ID: 9834619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma predilution with addition of depleted plasma in a prothrombin time reagent improves the agreement between different prothrombin time methods.
    Osman A; Lindahl TL
    Scand J Clin Lab Invest; 2009; 69(3):395-400. PubMed ID: 19191068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variability of INR due to thromboplastin. Comparison of two recombinant thromboplastins and one rabbit thromboplastin].
    Renier JL; Baufine-Ducrocq H; Samama MM
    Ann Biol Clin (Paris); 1995; 53(6):353-6. PubMed ID: 8572381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of inaccurate blood sample volume on prothrombin time (PT) and activated partial thromboplastin time (aPTT).
    Peterson P; Gottfried EL
    Thromb Haemost; 1982 Apr; 47(2):101-3. PubMed ID: 7101228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.